Crown Bioscience International

Crown Bioscience International is a leading provider of cutting-edge preclinical and translational research services, committed to advancing drug discovery and development. Our comprehensive suite of services includes state-of-the-art biomarker discovery to identify and validate biomarkers, DMPK services for in-depth analysis of drug metabolism and pharmacokinetics, and a wide range of laboratory services for accurate and reliable results. We offer robust pharmacology and bioanalytical services to support drug quantification and biomarker analysis, thorough toxicology assessments to ensure drug safety, and rigorous efficacy testing to evaluate therapeutic potential. Additionally, our high-throughput screening services help identify and characterize lead compounds quickly.

With a strong focus on innovation, we utilize advanced in vivo and in vitro models to generate meaningful preclinical data, guiding strategic decision-making for our clients. Our team of expert scientists is committed to delivering customized solutions, ensuring each project receives meticulous attention to detail. We continuously integrate the latest technological advancements to enhance research outcomes, supporting biotech and pharmaceutical companies in accelerating drug development.

At Crown Bioscience International, we believe in delivering high-quality, reliable, and timely research services to support your drug discovery programs. Partner with us to leverage our state-of-the-art technologies and extensive industry experience, helping you bring innovative therapies to market faster. Contact us today to learn how we can support your research needs and help advance the future of medicine.